Find me an approved drug that I can repurpose as an antiulcer/gastroprotective agent and evaluate in an experimentally induced gastric ulcer animal model, preferably in Wistar albino rats. I am an M.Pharm Pharmacology Semester 3 student, and I need a novel, low-cost, easily available, scientifically rational, and feasible drug for my M.Pharm research project. My requirements - The drug must already be approved for another therapeutic indication, so it qualifies as a drug-repurposing candidate. - It should be cheap and affordable for an M.Pharm student project. - It should be easily available in India. - It should preferably have a reasonable safety profile and be feasible for a preclinical animal study, subject to IAEC approval. - Most importantly, it should have minimal or no previous direct studies as an antiulcer/gastroprotective agent. - Prefer a drug that has not previously been evaluated in the specific proposed ulcer model. - Do NOT suggest drugs that are already extensively established as antiulcer drugs, such as omeprazole, pantoprazole, famotidine, sucralfate, etc. - The drug should have a strong pharmacological rationale explaining why it could potentially prevent gastric mucosal injury or promote ulcer healing. Potential mechanisms to investigate Look for drugs that may influence one or more of the following: - Gastric acid secretion - H+/K+-ATPase-related pathways - Gastric mucus secretion - Bicarbonate secretion - Gastric mucosal blood flow - Prostaglandin synthesis - PGE2 - Nitric oxide (NO) - Oxidative stress - Lipid peroxidation/MDA - Glutathione (GSH) - SOD - Catalase - Nrf2/ARE pathway - NF-κB signaling - TNF-α - IL-1β / IL-6 - Apoptosis - Caspase-3 - Mitochondrial dysfunction - Inflammation - Angiogenesis - Epithelial regeneration - Gastric mucosal repair - Other scientifically relevant gastroprotective mechanisms. IMPORTANT: Literature and novelty screening Before recommending any drug, perform a careful literature search using PubMed, Google Scholar, and other reliable scientific databases where available. Search combinations such as: - "[Drug] antiulcer" - "[Drug] anti-ulcer" - "[Drug] gastroprotective" - "[Drug] gastric protection" - "[Drug] gastric ulcer" - "[Drug] gastric mucosal protection" - "[Drug] peptic ulcer" - "[Drug] ulcer healing" - "[Drug] gastric oxidative stress" - "[Drug] gastric inflammation" - "[Drug] gastric mucosal injury" - "[Drug] ethanol-induced gastric ulcer" - "[Drug] indomethacin-induced gastric ulcer" - "[Drug] aspirin-induced gastric ulcer" - "[Drug] pylorus ligation" - "[Drug] acetic acid-induced gastric ulcer" Also search synonyms, alternative spellings, drug metabolites, and relevant mechanisms. Experimental ulcer models Consider established animal models such as: - Ethanol-induced gastric ulcer - Indomethacin-induced gastric ulcer - Aspirin-induced gastric ulcer - NSAID-induced gastric ulcer - Pylorus ligation-induced gastric ulcer - Acetic acid-induced chronic gastric ulcer - Other scientifically justified gastric ulcer models. For each candidate, determine whether the drug + specific ulcer model has already been studied. For every candidate provide 1. Drug name 2. Drug class 3. Current approved indication 4. Why it could potentially produce antiulcer/gastroprotective effects 5. Detailed mechanism of action 6. Molecular target/pathway involved 7. Scientific evidence supporting the proposed mechanism 8. Previous antiulcer studies 9. Previous gastroprotective studies 10. Previous animal ulcer studies 11. Which ulcer models have already been studied 12. Whether the proposed drug + ulcer model combination is already studied 13. Research gap 14. Novelty assessment 15. Potential adverse effects and limitations 16. Potential interaction with the ulcer-inducing agent 17. Approximate cost and availability in India 18. Suitable animal species 19. Possible route of administration 20. Suitable ulcer induction model 21. Suitable standard/positive control 22. Potential biochemical parameters 23. Potential histopathological parameters 24. Complete scientific justification for the M.Pharm project Suggested evaluation parameters Macroscopic parameters: - Ulcer index - Number of ulcers - Ulcer score/severity - Percentage protection - Gastric lesion area Gastric secretion parameters, where relevant: - Gastric volume - Gastric pH - Free acidity - Total acidity Mucosal protection parameters: - Gastric mucus - Mucosal glycoproteins - PGE2 - NO Oxidative stress parameters: - MDA - GSH - SOD - Catalase Inflammatory/molecular parameters, if feasible: - TNF-α - IL-1β - IL-6 - NF-κB - Nrf2 - Caspase-3 - Other relevant biomarkers. Histopathology: - Gastric mucosal erosion - Ulceration - Hemorrhage - Edema - Inflammatory-cell infiltration - Necrosis - Epithelial regeneration - Mucosal architecture. Novelty classification Classify every candidate as: A — Highly Novel: No convincing previous direct preclinical study was found evaluating the drug as an antiulcer/gastroprotective agent. B — Potentially Novel: Limited evidence exists, but the proposed ulcer model, mechanism, drug combination, or research question appears unexplored. C — Not Novel: The drug has already been extensively studied for antiulcer/gastroprotective effects and should not be selected for a novel M.Pharm project. Only recommend Category A or strong Category B candidates. Final selection Give me 5–10 potential approved drug candidates and compare them based on: Novelty + Mechanistic Rationale + Literature Gap + Low Cost + Availability in India + Safety + Animal-study Feasibility + M.Pharm Project Suitability. Then identify the Top 3 candidates and explain each one using this simple flow: Approved drug for another disease ↓ Known pharmacological action ↓ Target/pathway relevant to gastric injury ↓ Proposed gastroprotective/antiulcer mechanism ↓ Suitable experimental ulcer model ↓ Expected biochemical changes ↓ Expected reduction in ulcer index ↓ Expected histopathological improvement ↓ Research gap/novelty For the final selected candidate, provide: - Possible M.Pharm project title - Problem statement - Hypothesis - Scientific rationale - Aim - Objectives - Proposed experimental model - Major evaluation parameters - Expected outcome - Novelty statement - Why this project is suitable for an M.Pharm Pharmacology Semester 3 student Very important Do NOT say a drug is "never studied" merely because you did not find a paper. Clearly distinguish between: "No relevant study was identified in the searched literature" and "The drug has definitively never been studied." The final candidate should be affordable, easily available in India, scientifically rational, experimentally feasible, and sufficiently novel to justify an M.Pharm Pharmacology Semester 3 project and IAEC presentation.

Perform a PubMed and web novelty screen for 8 candidate drugs